Counted at 18:07:51 UTC. These figures count ledger entries that have a record hash, the same entries as the total. The newest of them was added at 18:07:48 UTC on 2026-10-27. Entries are added in batches when MAP checks its feeds, so the figures vary through the day.
News & Coverage
Latest News World Politics Business Technology Healthcare Entertainment Sports InstitutionalMAP Intelligence
MAP Intelligence Hub Business Intelligence Technology Intelligence Healthcare Intelligence Sports Intelligence Entertainment Intelligence What Changed EntitiesMAP Context™
MAP Context™ Context Analysis Narrative Analysis Media Context Reports Source Context Reports Transparency Explanations
Feed excerpt — reported by STAT News
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →
Original Source
This article was syndicated from STAT News. All rights remain with the original publisher.
